Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Molecular Psychiatry|June 9, 2005
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophreniaC S Weickert, D L Ligons, T Romanczyk, et al.
Molecular Psychiatry|January 9, 2013
Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expressionY Kunii, T M Hyde, T Ye, et al.
Experimental Neurology|March 17, 1998
Abnormal expression of cell recognition molecules in schizophreniaM P Vawter, H E Cannon-Spoor, J J Hemperly, et al.
Translational Psychiatry|March 1, 2017
High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortexJ K Lauridsen, R H Olesen, J Vendelbo, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 24, 2001
Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophreniaC S Weickert, M J Webster, T M Hyde, et al.
Science (New York, N.Y.)|August 30, 1996
Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor bindingS S Wolf, D W Jones, M B Knable, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 1995
Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophreniaA M Murray, T M Hyde, M B Knable, et al.
The American Journal of Psychiatry|June 1, 1992
Treatment of tardive dyskinesia with vitamin EM F Egan, T M Hyde, G W Albers, et al.
Cerebral Cortex (New York, N.Y. : 1991)|January 4, 1998
A qualitative and quantitative analysis of the entorhinal cortex in schizophreniaL S Krimer, M M Herman, R C Saunders, et al.
The Pharmacogenomics Journal|March 12, 2003
Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuseE Lehrmann, J Oyler, M P Vawter, et al.
Pageof 11